Staffan Welin

3.9k total citations · 2 hit papers
67 papers, 2.7k citations indexed

About

Staffan Welin is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Staffan Welin has authored 67 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 51 papers in Oncology and 45 papers in Neurology. Recurrent topics in Staffan Welin's work include Neuroendocrine Tumor Research Advances (61 papers), Neuroblastoma Research and Treatments (45 papers) and Lung Cancer Research Studies (42 papers). Staffan Welin is often cited by papers focused on Neuroendocrine Tumor Research Advances (61 papers), Neuroblastoma Research and Treatments (45 papers) and Lung Cancer Research Studies (42 papers). Staffan Welin collaborates with scholars based in Sweden, France and United States. Staffan Welin's co-authors include Eva Tiensuu Janson, Halfdan Sørbye, Barbro Eriksson, Ulrich Knigge, Henning Grønbæk, Seppo W. Langer, Birgitte Federspiel, Donald Granberg, Espen Thiis‐Evensen and Kjell Öberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Staffan Welin

63 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

2012 714 citations Halfdan Sørbye, Staffan Welin et al. Annals of Oncology profile →
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

2023 95 citations Johannes Hofland, Massimo Falconi et al. Journal of Neuroendocrinology profile →

Peers

Countries citing papers authored by Staffan Welin

Since Specialization

Citations

This map shows the geographic impact of Staffan Welin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Staffan Welin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Staffan Welin more than expected).

Fields of papers citing papers by Staffan Welin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Staffan Welin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Staffan Welin. The network helps show where Staffan Welin may publish in the future.

Co-authorship network of co-authors of Staffan Welin

This figure shows the co-authorship network connecting the top 25 collaborators of Staffan Welin. A scholar is included among the top collaborators of Staffan Welin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Staffan Welin. Staffan Welin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Controversies in NEN : An ENETS position statement on the management of locally advanced neuroendocrine neoplasia of the small intestine and pancreas without distant metastases 2025 ·Journal of Neuroendocrinology ·Margot Tesselaar, Stefano Partelli, Arthur J. A. T. Braat, (unknown), Ana Paula Santos, J. Schrader, Staffan Welin, Emanuel Christ, (unknown), (unknown)	0
2	European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes breakdown → 2023 ·Journal of Neuroendocrinology ·Johannes Hofland, Massimo Falconi, Emanuel Christ, Justo P. Castaño, Antongiulio Faggiano, Ángela Lamarca, Aurel Perren, Simona Petrucci, Vikas Prasad, Philippe Ruszniewski, Christina Thirlwell, Marie‐Pierre Vullierme, Staffan Welin, Detlef K. Bartsch	95
3	Real‐world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours 2022 ·Journal of Neuroendocrinology ·(unknown), (unknown), David J. Murphy, Rachel Crowley, Christos Toumpanakis, Staffan Welin, Donal O’Shea, Dermot O’Toole	8
4	Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors 2022 ·Neuroendocrinology ·Jaume Capdevila, Michel Ducreux, Rocio García‐Carbonero, Enrique Grande, Þorvarður R. Hálfdánarson, (unknown), Salvatore Tafuto, Staffan Welin, Vicente Valentí, Ramón Salazar	22
5	Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors 2022 ·Journal of Neuroendocrinology ·Espen Thiis‐Evensen, Magnus Kjellman, Ulrich Knigge, Henning Grønbæk, Camilla Schalin‐Jäntti, Staffan Welin, Halfdan Sørbye, Maria del Pilar Schneider, Roger Belusa, (unknown)	7
6	Adrenalectomy in ectopic Cushing’s syndrome: A retrospective cohort study from a tertiary care centre 2021 ·Journal of Neuroendocrinology ·(unknown), Malin Grönberg, Olov Norlén, Peter Stålberg, Staffan Welin, Eva Tiensuu Janson	5
7	⁶⁸ Ga‐DOTATOC‐PET/MRI and ¹¹ C‐5‐HTP‐PET/MRI are superior to ⁶⁸ Ga‐DOTATOC‐PET/CT for neuroendocrine tumour imaging 2021 ·Journal of Neuroendocrinology ·(unknown), Irina Velikyan, Staffan Welin, Anders Sundin	13
8	ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Éric Raymond, Lisa Bodei, Halfdan Sørbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James C. Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad	13
9	PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 2020 ·PLoS ONE ·(unknown), Seppo W. Langer, Birgitte Federspiel, Geir Olav Hjortland, Henning Grønbæk, Morten Ladekarl, Staffan Welin, Lene Weber Vestermark, Johanna Arola, Pia Österlund, Ulrich Knigge, Halfdan Sørbye, Patrick Micke, Lars Grimelius, Malin Grönberg, Eva Tiensuu Janson	14
10	High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors 2019 ·Neuroendocrinology ·Johan Botling, Ángela Lamarca, (unknown), Olov Norlén, (unknown), (unknown), Barbro Eriksson, Staffan Welin, Per Hellman, Guido Rindi, Britt Skogseid, Joakim Crona	45
11	Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3) 2018 ·Medical Oncology ·(unknown), Malin Grönberg, Seppo W. Langer, Morten Ladekarl, Geir Olav Hjortland, Lene Weber Vestermark, Pia Österlund, Staffan Welin, Henning Grønbæk, Ulrich Knigge, Halfdan Sørbye, Eva Tiensuu Janson	10
12	Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period 2018 ·Pancreas ·Martin O. Weickert, Gregory Kaltsas, Dieter Hörsch, Pablo Lapuerta, Marianne Pavel, Juan W. Valle, Martyn Caplin, Emily K. Bergsland, Pamela L. Kunz, Lowell Anthony, Enrique Grande, Kjell Öberg, Staffan Welin, Richard R.P. Warner, Catherine Lombard‐Bohas, (unknown), (unknown), (unknown), Qi Yang, Matthew H. Kulke	2
13	Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3) 2018 ·Neuroendocrinology ·Halfdan Sørbye, Éric Baudin, Ivan Borbath, Martyn Caplin, Jie Chen, Jarosław B. Ćwikła, Andrea Frilling, Ashley Grossman, Gregory Kaltsas, Aldo Scarpa, Staffan Welin, Rocio García‐Carbonero, (unknown)	65
14	Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl : Analysis of the Phase 3 TELESTAR Study 2018 ·Pancreas ·Joseph S. Dillon, Matthew H. Kulke, Marianne Pavel, Dieter Hörsch, Lowell Anthony, Richard R.P. Warner, Emily K. Bergsland, Staffan Welin, Thomas M. O’Dorisio, Nilay Patel, Pablo Lapuerta	2
15	Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms 2018 ·Neuroendocrinology ·Robert T. Jensen, Lisa Bodei, Jaume Capdevila, Anne Couvelard, Massimo Falconi, Simona Grozinsky‐Glasberg, Günter Klöppel, Steven W. J. Lamberts, Marc Peeters, Guido Rindi, Anja Rinke, M Rothmund, Anders Sundin, Staffan Welin, Nicola Fazio, (unknown)	42
16	Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma 2017 ·PLoS ONE ·(unknown), Malin Grönberg, Birgitte Federspiel, Jean‐Yves Scoazec, Geir Olav Hjortland, Henning Grønbæk, Morten Ladekarl, Seppo W. Langer, Staffan Welin, Lene Weber Vestermark, Johanna Arola, Pia Österlund, Ulrich Knigge, Halfdan Sørbye, Lars Grimelius, Eva Tiensuu Janson	27
17	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification 2017 ·Neuroendocrinology ·Aurel Perren, Anne Couvelard, Jean‐Yves Scoazec, (unknown), Ivan Borbath, Gianfranco Delle Fave, Vera Gorbounova, David J. Gross, Ashley Grossman, Robert T. Jensen, Matthew H. Kulke, Kjell Öberg, Guido Rindi, Halfdan Sørbye, Staffan Welin, (unknown)	165
18	Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors: A Retrospective Swedish Study 2017 ·Value in Health ·Åse Björstad, Thomas Marlow, Eva Lesén, Entela Bollano, Florence Marteau, Sylvie Gabriel, Staffan Welin, (unknown)	1
19	Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial 2016 ·Pancreas ·Matthew H. Kulke, Dieter Hoersch, Martyn Caplin, Lowell Anthony, Emily K. Bergsland, Kjell Öberg, Staffan Welin, Richard R.P. Warner, Catherine Lombard‐Bohas, Pamela L. Kunz, Enrique Grande, Juan W. Valle, Douglas Fleming, Pablo Lapuerta, Phillip Banks, Shanna Jackson, (unknown), Brian Zambrowicz, Arthur Sands, Marianne Pavel	1
20	Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome 2016 ·Annals of Oncology ·Matthew H. Kulke, Dieter Hörsch, Martyn Caplin, Lowell Anthony, Emily K. Bergsland, Kjell Öberg, Staffan Welin, Robert R. Warner, C. Lombard Bohas, Pamela L. Kunz, Enrique Grande, Juan W. Valle, Pablo Lapuerta, Phillip Banks, Shanna Jackson, Wenjun Jiang, (unknown), Marianne Pavel	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact